Global Drug Safety Testing Market Research Report 2024(Status and Outlook)
Report Overview
The drug safety testing service is a commercial service that helps pharmaceutical companies and other companies to conduct drug component analysis and safety testing
The global Drug Safety Testing market size was estimated at USD 7120 million in 2023 and is projected to reach USD 24060.73 million by 2030, exhibiting a CAGR of 19.00% during the forecast period.
North America Drug Safety Testing market size was USD 1855.27 million in 2023, at a CAGR of 16.29% during the forecast period of 2024 through 2030.
This report provides a deep insight into the global Drug Safety Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug Safety Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug Safety Testing market in any manner.
Global Drug Safety Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
ArisGlobal LLC
Eurofins
Clario
Charles River
Pace Analytical Services
LabCorp
ICON plc.
Boston Analytical
Catalent
Parexel International Corporation
Altasciences
Hangzhou Huante Biotechnology Co.
Ltd.
Boende Testing
Microspectroscopy Technology Co.
Ltd.
Pharmaron
JOINN
Shanghai InnoStar Bio-tech Co.
Ltd
WESTCHINA-FRONTIE PHARMA TECH
Shanghai Medicilon
Hangzhou Rongchuang Biological Co.
Ltd.
WuXi AppTec
Market Segmentation (by Type)
Drug Testing
Drug Analysis
Market Segmentation (by Application)
Pharmaceutical Company
Biotechnology Company
Medical Device Manufacturer
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug Safety Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 12 is the main points and conclusions of the report.
The drug safety testing service is a commercial service that helps pharmaceutical companies and other companies to conduct drug component analysis and safety testing
The global Drug Safety Testing market size was estimated at USD 7120 million in 2023 and is projected to reach USD 24060.73 million by 2030, exhibiting a CAGR of 19.00% during the forecast period.
North America Drug Safety Testing market size was USD 1855.27 million in 2023, at a CAGR of 16.29% during the forecast period of 2024 through 2030.
This report provides a deep insight into the global Drug Safety Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug Safety Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug Safety Testing market in any manner.
Global Drug Safety Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
ArisGlobal LLC
Eurofins
Clario
Charles River
Pace Analytical Services
LabCorp
ICON plc.
Boston Analytical
Catalent
Parexel International Corporation
Altasciences
Hangzhou Huante Biotechnology Co.
Ltd.
Boende Testing
Microspectroscopy Technology Co.
Ltd.
Pharmaron
JOINN
Shanghai InnoStar Bio-tech Co.
Ltd
WESTCHINA-FRONTIE PHARMA TECH
Shanghai Medicilon
Hangzhou Rongchuang Biological Co.
Ltd.
WuXi AppTec
Market Segmentation (by Type)
Drug Testing
Drug Analysis
Market Segmentation (by Application)
Pharmaceutical Company
Biotechnology Company
Medical Device Manufacturer
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Drug Safety Testing Market
- Overview of the regional outlook of the Drug Safety Testing Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug Safety Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Drug Safety Testing
1.2 Key Market Segments
1.2.1 Drug Safety Testing Segment by Type
1.2.2 Drug Safety Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DRUG SAFETY TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DRUG SAFETY TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global Drug Safety Testing Revenue Market Share by Company (2019-2024)
3.2 Drug Safety Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Drug Safety Testing Market Size Sites, Area Served, Product Type
3.4 Drug Safety Testing Market Competitive Situation and Trends
3.4.1 Drug Safety Testing Market Concentration Rate
3.4.2 Global 5 and 10 Largest Drug Safety Testing Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 DRUG SAFETY TESTING VALUE CHAIN ANALYSIS
4.1 Drug Safety Testing Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DRUG SAFETY TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 DRUG SAFETY TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug Safety Testing Market Size Market Share by Type (2019-2024)
6.3 Global Drug Safety Testing Market Size Growth Rate by Type (2019-2024)
7 DRUG SAFETY TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug Safety Testing Market Size (M USD) by Application (2019-2024)
7.3 Global Drug Safety Testing Market Size Growth Rate by Application (2019-2024)
8 DRUG SAFETY TESTING MARKET SEGMENTATION BY REGION
8.1 Global Drug Safety Testing Market Size by Region
8.1.1 Global Drug Safety Testing Market Size by Region
8.1.2 Global Drug Safety Testing Market Size Market Share by Region
8.2 North America
8.2.1 North America Drug Safety Testing Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Drug Safety Testing Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Drug Safety Testing Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Drug Safety Testing Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Drug Safety Testing Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 ArisGlobal LLC
9.1.1 ArisGlobal LLC Drug Safety Testing Basic Information
9.1.2 ArisGlobal LLC Drug Safety Testing Product Overview
9.1.3 ArisGlobal LLC Drug Safety Testing Product Market Performance
9.1.4 ArisGlobal LLC Drug Safety Testing SWOT Analysis
9.1.5 ArisGlobal LLC Business Overview
9.1.6 ArisGlobal LLC Recent Developments
9.2 Eurofins
9.2.1 Eurofins Drug Safety Testing Basic Information
9.2.2 Eurofins Drug Safety Testing Product Overview
9.2.3 Eurofins Drug Safety Testing Product Market Performance
9.2.4 Eurofins Drug Safety Testing SWOT Analysis
9.2.5 Eurofins Business Overview
9.2.6 Eurofins Recent Developments
9.3 Clario
9.3.1 Clario Drug Safety Testing Basic Information
9.3.2 Clario Drug Safety Testing Product Overview
9.3.3 Clario Drug Safety Testing Product Market Performance
9.3.4 Clario Drug Safety Testing SWOT Analysis
9.3.5 Clario Business Overview
9.3.6 Clario Recent Developments
9.4 Charles River
9.4.1 Charles River Drug Safety Testing Basic Information
9.4.2 Charles River Drug Safety Testing Product Overview
9.4.3 Charles River Drug Safety Testing Product Market Performance
9.4.4 Charles River Business Overview
9.4.5 Charles River Recent Developments
9.5 Pace Analytical Services
9.5.1 Pace Analytical Services Drug Safety Testing Basic Information
9.5.2 Pace Analytical Services Drug Safety Testing Product Overview
9.5.3 Pace Analytical Services Drug Safety Testing Product Market Performance
9.5.4 Pace Analytical Services Business Overview
9.5.5 Pace Analytical Services Recent Developments
9.6 LabCorp
9.6.1 LabCorp Drug Safety Testing Basic Information
9.6.2 LabCorp Drug Safety Testing Product Overview
9.6.3 LabCorp Drug Safety Testing Product Market Performance
9.6.4 LabCorp Business Overview
9.6.5 LabCorp Recent Developments
9.7 ICON plc.
9.7.1 ICON plc. Drug Safety Testing Basic Information
9.7.2 ICON plc. Drug Safety Testing Product Overview
9.7.3 ICON plc. Drug Safety Testing Product Market Performance
9.7.4 ICON plc. Business Overview
9.7.5 ICON plc. Recent Developments
9.8 Boston Analytical
9.8.1 Boston Analytical Drug Safety Testing Basic Information
9.8.2 Boston Analytical Drug Safety Testing Product Overview
9.8.3 Boston Analytical Drug Safety Testing Product Market Performance
9.8.4 Boston Analytical Business Overview
9.8.5 Boston Analytical Recent Developments
9.9 Catalent
9.9.1 Catalent Drug Safety Testing Basic Information
9.9.2 Catalent Drug Safety Testing Product Overview
9.9.3 Catalent Drug Safety Testing Product Market Performance
9.9.4 Catalent Business Overview
9.9.5 Catalent Recent Developments
9.10 Parexel International Corporation
9.10.1 Parexel International Corporation Drug Safety Testing Basic Information
9.10.2 Parexel International Corporation Drug Safety Testing Product Overview
9.10.3 Parexel International Corporation Drug Safety Testing Product Market Performance
9.10.4 Parexel International Corporation Business Overview
9.10.5 Parexel International Corporation Recent Developments
9.11 Altasciences
9.11.1 Altasciences Drug Safety Testing Basic Information
9.11.2 Altasciences Drug Safety Testing Product Overview
9.11.3 Altasciences Drug Safety Testing Product Market Performance
9.11.4 Altasciences Business Overview
9.11.5 Altasciences Recent Developments
9.12 Hangzhou Huante Biotechnology Co.
9.12.1 Hangzhou Huante Biotechnology Co. Drug Safety Testing Basic Information
9.12.2 Hangzhou Huante Biotechnology Co. Drug Safety Testing Product Overview
9.12.3 Hangzhou Huante Biotechnology Co. Drug Safety Testing Product Market Performance
9.12.4 Hangzhou Huante Biotechnology Co. Business Overview
9.12.5 Hangzhou Huante Biotechnology Co. Recent Developments
9.13 Ltd.
9.13.1 Ltd. Drug Safety Testing Basic Information
9.13.2 Ltd. Drug Safety Testing Product Overview
9.13.3 Ltd. Drug Safety Testing Product Market Performance
9.13.4 Ltd. Business Overview
9.13.5 Ltd. Recent Developments
9.14 Boende Testing
9.14.1 Boende Testing Drug Safety Testing Basic Information
9.14.2 Boende Testing Drug Safety Testing Product Overview
9.14.3 Boende Testing Drug Safety Testing Product Market Performance
9.14.4 Boende Testing Business Overview
9.14.5 Boende Testing Recent Developments
9.15 Microspectroscopy Technology Co.
9.15.1 Microspectroscopy Technology Co. Drug Safety Testing Basic Information
9.15.2 Microspectroscopy Technology Co. Drug Safety Testing Product Overview
9.15.3 Microspectroscopy Technology Co. Drug Safety Testing Product Market Performance
9.15.4 Microspectroscopy Technology Co. Business Overview
9.15.5 Microspectroscopy Technology Co. Recent Developments
9.16 Ltd.
9.16.1 Ltd. Drug Safety Testing Basic Information
9.16.2 Ltd. Drug Safety Testing Product Overview
9.16.3 Ltd. Drug Safety Testing Product Market Performance
9.16.4 Ltd. Business Overview
9.16.5 Ltd. Recent Developments
9.17 Pharmaron
9.17.1 Pharmaron Drug Safety Testing Basic Information
9.17.2 Pharmaron Drug Safety Testing Product Overview
9.17.3 Pharmaron Drug Safety Testing Product Market Performance
9.17.4 Pharmaron Business Overview
9.17.5 Pharmaron Recent Developments
9.18 JOINN
9.18.1 JOINN Drug Safety Testing Basic Information
9.18.2 JOINN Drug Safety Testing Product Overview
9.18.3 JOINN Drug Safety Testing Product Market Performance
9.18.4 JOINN Business Overview
9.18.5 JOINN Recent Developments
9.19 Shanghai InnoStar Bio-tech Co.
9.19.1 Shanghai InnoStar Bio-tech Co. Drug Safety Testing Basic Information
9.19.2 Shanghai InnoStar Bio-tech Co. Drug Safety Testing Product Overview
9.19.3 Shanghai InnoStar Bio-tech Co. Drug Safety Testing Product Market Performance
9.19.4 Shanghai InnoStar Bio-tech Co. Business Overview
9.19.5 Shanghai InnoStar Bio-tech Co. Recent Developments
9.20 Ltd
9.20.1 Ltd Drug Safety Testing Basic Information
9.20.2 Ltd Drug Safety Testing Product Overview
9.20.3 Ltd Drug Safety Testing Product Market Performance
9.20.4 Ltd Business Overview
9.20.5 Ltd Recent Developments
9.21 WESTCHINA-FRONTIE PHARMA TECH
9.21.1 WESTCHINA-FRONTIE PHARMA TECH Drug Safety Testing Basic Information
9.21.2 WESTCHINA-FRONTIE PHARMA TECH Drug Safety Testing Product Overview
9.21.3 WESTCHINA-FRONTIE PHARMA TECH Drug Safety Testing Product Market Performance
9.21.4 WESTCHINA-FRONTIE PHARMA TECH Business Overview
9.21.5 WESTCHINA-FRONTIE PHARMA TECH Recent Developments
9.22 Shanghai Medicilon
9.22.1 Shanghai Medicilon Drug Safety Testing Basic Information
9.22.2 Shanghai Medicilon Drug Safety Testing Product Overview
9.22.3 Shanghai Medicilon Drug Safety Testing Product Market Performance
9.22.4 Shanghai Medicilon Business Overview
9.22.5 Shanghai Medicilon Recent Developments
9.23 Hangzhou Rongchuang Biological Co.
9.23.1 Hangzhou Rongchuang Biological Co. Drug Safety Testing Basic Information
9.23.2 Hangzhou Rongchuang Biological Co. Drug Safety Testing Product Overview
9.23.3 Hangzhou Rongchuang Biological Co. Drug Safety Testing Product Market Performance
9.23.4 Hangzhou Rongchuang Biological Co. Business Overview
9.23.5 Hangzhou Rongchuang Biological Co. Recent Developments
9.24 Ltd.
9.24.1 Ltd. Drug Safety Testing Basic Information
9.24.2 Ltd. Drug Safety Testing Product Overview
9.24.3 Ltd. Drug Safety Testing Product Market Performance
9.24.4 Ltd. Business Overview
9.24.5 Ltd. Recent Developments
9.25 WuXi AppTec
9.25.1 WuXi AppTec Drug Safety Testing Basic Information
9.25.2 WuXi AppTec Drug Safety Testing Product Overview
9.25.3 WuXi AppTec Drug Safety Testing Product Market Performance
9.25.4 WuXi AppTec Business Overview
9.25.5 WuXi AppTec Recent Developments
10 DRUG SAFETY TESTING REGIONAL MARKET FORECAST
10.1 Global Drug Safety Testing Market Size Forecast
10.2 Global Drug Safety Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Drug Safety Testing Market Size Forecast by Country
10.2.3 Asia Pacific Drug Safety Testing Market Size Forecast by Region
10.2.4 South America Drug Safety Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Drug Safety Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Drug Safety Testing Market Forecast by Type (2025-2030)
11.2 Global Drug Safety Testing Market Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Drug Safety Testing
1.2 Key Market Segments
1.2.1 Drug Safety Testing Segment by Type
1.2.2 Drug Safety Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DRUG SAFETY TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DRUG SAFETY TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global Drug Safety Testing Revenue Market Share by Company (2019-2024)
3.2 Drug Safety Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Drug Safety Testing Market Size Sites, Area Served, Product Type
3.4 Drug Safety Testing Market Competitive Situation and Trends
3.4.1 Drug Safety Testing Market Concentration Rate
3.4.2 Global 5 and 10 Largest Drug Safety Testing Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 DRUG SAFETY TESTING VALUE CHAIN ANALYSIS
4.1 Drug Safety Testing Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DRUG SAFETY TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 DRUG SAFETY TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug Safety Testing Market Size Market Share by Type (2019-2024)
6.3 Global Drug Safety Testing Market Size Growth Rate by Type (2019-2024)
7 DRUG SAFETY TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug Safety Testing Market Size (M USD) by Application (2019-2024)
7.3 Global Drug Safety Testing Market Size Growth Rate by Application (2019-2024)
8 DRUG SAFETY TESTING MARKET SEGMENTATION BY REGION
8.1 Global Drug Safety Testing Market Size by Region
8.1.1 Global Drug Safety Testing Market Size by Region
8.1.2 Global Drug Safety Testing Market Size Market Share by Region
8.2 North America
8.2.1 North America Drug Safety Testing Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Drug Safety Testing Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Drug Safety Testing Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Drug Safety Testing Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Drug Safety Testing Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 ArisGlobal LLC
9.1.1 ArisGlobal LLC Drug Safety Testing Basic Information
9.1.2 ArisGlobal LLC Drug Safety Testing Product Overview
9.1.3 ArisGlobal LLC Drug Safety Testing Product Market Performance
9.1.4 ArisGlobal LLC Drug Safety Testing SWOT Analysis
9.1.5 ArisGlobal LLC Business Overview
9.1.6 ArisGlobal LLC Recent Developments
9.2 Eurofins
9.2.1 Eurofins Drug Safety Testing Basic Information
9.2.2 Eurofins Drug Safety Testing Product Overview
9.2.3 Eurofins Drug Safety Testing Product Market Performance
9.2.4 Eurofins Drug Safety Testing SWOT Analysis
9.2.5 Eurofins Business Overview
9.2.6 Eurofins Recent Developments
9.3 Clario
9.3.1 Clario Drug Safety Testing Basic Information
9.3.2 Clario Drug Safety Testing Product Overview
9.3.3 Clario Drug Safety Testing Product Market Performance
9.3.4 Clario Drug Safety Testing SWOT Analysis
9.3.5 Clario Business Overview
9.3.6 Clario Recent Developments
9.4 Charles River
9.4.1 Charles River Drug Safety Testing Basic Information
9.4.2 Charles River Drug Safety Testing Product Overview
9.4.3 Charles River Drug Safety Testing Product Market Performance
9.4.4 Charles River Business Overview
9.4.5 Charles River Recent Developments
9.5 Pace Analytical Services
9.5.1 Pace Analytical Services Drug Safety Testing Basic Information
9.5.2 Pace Analytical Services Drug Safety Testing Product Overview
9.5.3 Pace Analytical Services Drug Safety Testing Product Market Performance
9.5.4 Pace Analytical Services Business Overview
9.5.5 Pace Analytical Services Recent Developments
9.6 LabCorp
9.6.1 LabCorp Drug Safety Testing Basic Information
9.6.2 LabCorp Drug Safety Testing Product Overview
9.6.3 LabCorp Drug Safety Testing Product Market Performance
9.6.4 LabCorp Business Overview
9.6.5 LabCorp Recent Developments
9.7 ICON plc.
9.7.1 ICON plc. Drug Safety Testing Basic Information
9.7.2 ICON plc. Drug Safety Testing Product Overview
9.7.3 ICON plc. Drug Safety Testing Product Market Performance
9.7.4 ICON plc. Business Overview
9.7.5 ICON plc. Recent Developments
9.8 Boston Analytical
9.8.1 Boston Analytical Drug Safety Testing Basic Information
9.8.2 Boston Analytical Drug Safety Testing Product Overview
9.8.3 Boston Analytical Drug Safety Testing Product Market Performance
9.8.4 Boston Analytical Business Overview
9.8.5 Boston Analytical Recent Developments
9.9 Catalent
9.9.1 Catalent Drug Safety Testing Basic Information
9.9.2 Catalent Drug Safety Testing Product Overview
9.9.3 Catalent Drug Safety Testing Product Market Performance
9.9.4 Catalent Business Overview
9.9.5 Catalent Recent Developments
9.10 Parexel International Corporation
9.10.1 Parexel International Corporation Drug Safety Testing Basic Information
9.10.2 Parexel International Corporation Drug Safety Testing Product Overview
9.10.3 Parexel International Corporation Drug Safety Testing Product Market Performance
9.10.4 Parexel International Corporation Business Overview
9.10.5 Parexel International Corporation Recent Developments
9.11 Altasciences
9.11.1 Altasciences Drug Safety Testing Basic Information
9.11.2 Altasciences Drug Safety Testing Product Overview
9.11.3 Altasciences Drug Safety Testing Product Market Performance
9.11.4 Altasciences Business Overview
9.11.5 Altasciences Recent Developments
9.12 Hangzhou Huante Biotechnology Co.
9.12.1 Hangzhou Huante Biotechnology Co. Drug Safety Testing Basic Information
9.12.2 Hangzhou Huante Biotechnology Co. Drug Safety Testing Product Overview
9.12.3 Hangzhou Huante Biotechnology Co. Drug Safety Testing Product Market Performance
9.12.4 Hangzhou Huante Biotechnology Co. Business Overview
9.12.5 Hangzhou Huante Biotechnology Co. Recent Developments
9.13 Ltd.
9.13.1 Ltd. Drug Safety Testing Basic Information
9.13.2 Ltd. Drug Safety Testing Product Overview
9.13.3 Ltd. Drug Safety Testing Product Market Performance
9.13.4 Ltd. Business Overview
9.13.5 Ltd. Recent Developments
9.14 Boende Testing
9.14.1 Boende Testing Drug Safety Testing Basic Information
9.14.2 Boende Testing Drug Safety Testing Product Overview
9.14.3 Boende Testing Drug Safety Testing Product Market Performance
9.14.4 Boende Testing Business Overview
9.14.5 Boende Testing Recent Developments
9.15 Microspectroscopy Technology Co.
9.15.1 Microspectroscopy Technology Co. Drug Safety Testing Basic Information
9.15.2 Microspectroscopy Technology Co. Drug Safety Testing Product Overview
9.15.3 Microspectroscopy Technology Co. Drug Safety Testing Product Market Performance
9.15.4 Microspectroscopy Technology Co. Business Overview
9.15.5 Microspectroscopy Technology Co. Recent Developments
9.16 Ltd.
9.16.1 Ltd. Drug Safety Testing Basic Information
9.16.2 Ltd. Drug Safety Testing Product Overview
9.16.3 Ltd. Drug Safety Testing Product Market Performance
9.16.4 Ltd. Business Overview
9.16.5 Ltd. Recent Developments
9.17 Pharmaron
9.17.1 Pharmaron Drug Safety Testing Basic Information
9.17.2 Pharmaron Drug Safety Testing Product Overview
9.17.3 Pharmaron Drug Safety Testing Product Market Performance
9.17.4 Pharmaron Business Overview
9.17.5 Pharmaron Recent Developments
9.18 JOINN
9.18.1 JOINN Drug Safety Testing Basic Information
9.18.2 JOINN Drug Safety Testing Product Overview
9.18.3 JOINN Drug Safety Testing Product Market Performance
9.18.4 JOINN Business Overview
9.18.5 JOINN Recent Developments
9.19 Shanghai InnoStar Bio-tech Co.
9.19.1 Shanghai InnoStar Bio-tech Co. Drug Safety Testing Basic Information
9.19.2 Shanghai InnoStar Bio-tech Co. Drug Safety Testing Product Overview
9.19.3 Shanghai InnoStar Bio-tech Co. Drug Safety Testing Product Market Performance
9.19.4 Shanghai InnoStar Bio-tech Co. Business Overview
9.19.5 Shanghai InnoStar Bio-tech Co. Recent Developments
9.20 Ltd
9.20.1 Ltd Drug Safety Testing Basic Information
9.20.2 Ltd Drug Safety Testing Product Overview
9.20.3 Ltd Drug Safety Testing Product Market Performance
9.20.4 Ltd Business Overview
9.20.5 Ltd Recent Developments
9.21 WESTCHINA-FRONTIE PHARMA TECH
9.21.1 WESTCHINA-FRONTIE PHARMA TECH Drug Safety Testing Basic Information
9.21.2 WESTCHINA-FRONTIE PHARMA TECH Drug Safety Testing Product Overview
9.21.3 WESTCHINA-FRONTIE PHARMA TECH Drug Safety Testing Product Market Performance
9.21.4 WESTCHINA-FRONTIE PHARMA TECH Business Overview
9.21.5 WESTCHINA-FRONTIE PHARMA TECH Recent Developments
9.22 Shanghai Medicilon
9.22.1 Shanghai Medicilon Drug Safety Testing Basic Information
9.22.2 Shanghai Medicilon Drug Safety Testing Product Overview
9.22.3 Shanghai Medicilon Drug Safety Testing Product Market Performance
9.22.4 Shanghai Medicilon Business Overview
9.22.5 Shanghai Medicilon Recent Developments
9.23 Hangzhou Rongchuang Biological Co.
9.23.1 Hangzhou Rongchuang Biological Co. Drug Safety Testing Basic Information
9.23.2 Hangzhou Rongchuang Biological Co. Drug Safety Testing Product Overview
9.23.3 Hangzhou Rongchuang Biological Co. Drug Safety Testing Product Market Performance
9.23.4 Hangzhou Rongchuang Biological Co. Business Overview
9.23.5 Hangzhou Rongchuang Biological Co. Recent Developments
9.24 Ltd.
9.24.1 Ltd. Drug Safety Testing Basic Information
9.24.2 Ltd. Drug Safety Testing Product Overview
9.24.3 Ltd. Drug Safety Testing Product Market Performance
9.24.4 Ltd. Business Overview
9.24.5 Ltd. Recent Developments
9.25 WuXi AppTec
9.25.1 WuXi AppTec Drug Safety Testing Basic Information
9.25.2 WuXi AppTec Drug Safety Testing Product Overview
9.25.3 WuXi AppTec Drug Safety Testing Product Market Performance
9.25.4 WuXi AppTec Business Overview
9.25.5 WuXi AppTec Recent Developments
10 DRUG SAFETY TESTING REGIONAL MARKET FORECAST
10.1 Global Drug Safety Testing Market Size Forecast
10.2 Global Drug Safety Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Drug Safety Testing Market Size Forecast by Country
10.2.3 Asia Pacific Drug Safety Testing Market Size Forecast by Region
10.2.4 South America Drug Safety Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Drug Safety Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Drug Safety Testing Market Forecast by Type (2025-2030)
11.2 Global Drug Safety Testing Market Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Drug Safety Testing Market Size Comparison by Region (M USD)
Table 5. Global Drug Safety Testing Revenue (M USD) by Company (2019-2024)
Table 6. Global Drug Safety Testing Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Safety Testing as of 2022)
Table 8. Company Drug Safety Testing Market Size Sites and Area Served
Table 9. Company Drug Safety Testing Product Type
Table 10. Global Drug Safety Testing Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Drug Safety Testing
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Drug Safety Testing Market Challenges
Table 18. Global Drug Safety Testing Market Size by Type (M USD)
Table 19. Global Drug Safety Testing Market Size (M USD) by Type (2019-2024)
Table 20. Global Drug Safety Testing Market Size Share by Type (2019-2024)
Table 21. Global Drug Safety Testing Market Size Growth Rate by Type (2019-2024)
Table 22. Global Drug Safety Testing Market Size by Application
Table 23. Global Drug Safety Testing Market Size by Application (2019-2024) & (M USD)
Table 24. Global Drug Safety Testing Market Share by Application (2019-2024)
Table 25. Global Drug Safety Testing Market Size Growth Rate by Application (2019-2024)
Table 26. Global Drug Safety Testing Market Size by Region (2019-2024) & (M USD)
Table 27. Global Drug Safety Testing Market Size Market Share by Region (2019-2024)
Table 28. North America Drug Safety Testing Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Drug Safety Testing Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Drug Safety Testing Market Size by Region (2019-2024) & (M USD)
Table 31. South America Drug Safety Testing Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Drug Safety Testing Market Size by Region (2019-2024) & (M USD)
Table 33. ArisGlobal LLC Drug Safety Testing Basic Information
Table 34. ArisGlobal LLC Drug Safety Testing Product Overview
Table 35. ArisGlobal LLC Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 36. ArisGlobal LLC Drug Safety Testing SWOT Analysis
Table 37. ArisGlobal LLC Business Overview
Table 38. ArisGlobal LLC Recent Developments
Table 39. Eurofins Drug Safety Testing Basic Information
Table 40. Eurofins Drug Safety Testing Product Overview
Table 41. Eurofins Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 42. Eurofins Drug Safety Testing SWOT Analysis
Table 43. Eurofins Business Overview
Table 44. Eurofins Recent Developments
Table 45. Clario Drug Safety Testing Basic Information
Table 46. Clario Drug Safety Testing Product Overview
Table 47. Clario Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 48. Clario Drug Safety Testing SWOT Analysis
Table 49. Clario Business Overview
Table 50. Clario Recent Developments
Table 51. Charles River Drug Safety Testing Basic Information
Table 52. Charles River Drug Safety Testing Product Overview
Table 53. Charles River Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 54. Charles River Business Overview
Table 55. Charles River Recent Developments
Table 56. Pace Analytical Services Drug Safety Testing Basic Information
Table 57. Pace Analytical Services Drug Safety Testing Product Overview
Table 58. Pace Analytical Services Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 59. Pace Analytical Services Business Overview
Table 60. Pace Analytical Services Recent Developments
Table 61. LabCorp Drug Safety Testing Basic Information
Table 62. LabCorp Drug Safety Testing Product Overview
Table 63. LabCorp Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 64. LabCorp Business Overview
Table 65. LabCorp Recent Developments
Table 66. ICON plc. Drug Safety Testing Basic Information
Table 67. ICON plc. Drug Safety Testing Product Overview
Table 68. ICON plc. Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 69. ICON plc. Business Overview
Table 70. ICON plc. Recent Developments
Table 71. Boston Analytical Drug Safety Testing Basic Information
Table 72. Boston Analytical Drug Safety Testing Product Overview
Table 73. Boston Analytical Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 74. Boston Analytical Business Overview
Table 75. Boston Analytical Recent Developments
Table 76. Catalent Drug Safety Testing Basic Information
Table 77. Catalent Drug Safety Testing Product Overview
Table 78. Catalent Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 79. Catalent Business Overview
Table 80. Catalent Recent Developments
Table 81. Parexel International Corporation Drug Safety Testing Basic Information
Table 82. Parexel International Corporation Drug Safety Testing Product Overview
Table 83. Parexel International Corporation Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 84. Parexel International Corporation Business Overview
Table 85. Parexel International Corporation Recent Developments
Table 86. Altasciences Drug Safety Testing Basic Information
Table 87. Altasciences Drug Safety Testing Product Overview
Table 88. Altasciences Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 89. Altasciences Business Overview
Table 90. Altasciences Recent Developments
Table 91. Hangzhou Huante Biotechnology Co. Drug Safety Testing Basic Information
Table 92. Hangzhou Huante Biotechnology Co. Drug Safety Testing Product Overview
Table 93. Hangzhou Huante Biotechnology Co. Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 94. Hangzhou Huante Biotechnology Co. Business Overview
Table 95. Hangzhou Huante Biotechnology Co. Recent Developments
Table 96. Ltd. Drug Safety Testing Basic Information
Table 97. Ltd. Drug Safety Testing Product Overview
Table 98. Ltd. Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 99. Ltd. Business Overview
Table 100. Ltd. Recent Developments
Table 101. Boende Testing Drug Safety Testing Basic Information
Table 102. Boende Testing Drug Safety Testing Product Overview
Table 103. Boende Testing Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 104. Boende Testing Business Overview
Table 105. Boende Testing Recent Developments
Table 106. Microspectroscopy Technology Co. Drug Safety Testing Basic Information
Table 107. Microspectroscopy Technology Co. Drug Safety Testing Product Overview
Table 108. Microspectroscopy Technology Co. Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 109. Microspectroscopy Technology Co. Business Overview
Table 110. Microspectroscopy Technology Co. Recent Developments
Table 111. Ltd. Drug Safety Testing Basic Information
Table 112. Ltd. Drug Safety Testing Product Overview
Table 113. Ltd. Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 114. Ltd. Business Overview
Table 115. Ltd. Recent Developments
Table 116. Pharmaron Drug Safety Testing Basic Information
Table 117. Pharmaron Drug Safety Testing Product Overview
Table 118. Pharmaron Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 119. Pharmaron Business Overview
Table 120. Pharmaron Recent Developments
Table 121. JOINN Drug Safety Testing Basic Information
Table 122. JOINN Drug Safety Testing Product Overview
Table 123. JOINN Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 124. JOINN Business Overview
Table 125. JOINN Recent Developments
Table 126. Shanghai InnoStar Bio-tech Co. Drug Safety Testing Basic Information
Table 127. Shanghai InnoStar Bio-tech Co. Drug Safety Testing Product Overview
Table 128. Shanghai InnoStar Bio-tech Co. Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 129. Shanghai InnoStar Bio-tech Co. Business Overview
Table 130. Shanghai InnoStar Bio-tech Co. Recent Developments
Table 131. Ltd Drug Safety Testing Basic Information
Table 132. Ltd Drug Safety Testing Product Overview
Table 133. Ltd Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 134. Ltd Business Overview
Table 135. Ltd Recent Developments
Table 136. WESTCHINA-FRONTIE PHARMA TECH Drug Safety Testing Basic Information
Table 137. WESTCHINA-FRONTIE PHARMA TECH Drug Safety Testing Product Overview
Table 138. WESTCHINA-FRONTIE PHARMA TECH Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 139. WESTCHINA-FRONTIE PHARMA TECH Business Overview
Table 140. WESTCHINA-FRONTIE PHARMA TECH Recent Developments
Table 141. Shanghai Medicilon Drug Safety Testing Basic Information
Table 142. Shanghai Medicilon Drug Safety Testing Product Overview
Table 143. Shanghai Medicilon Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 144. Shanghai Medicilon Business Overview
Table 145. Shanghai Medicilon Recent Developments
Table 146. Hangzhou Rongchuang Biological Co. Drug Safety Testing Basic Information
Table 147. Hangzhou Rongchuang Biological Co. Drug Safety Testing Product Overview
Table 148. Hangzhou Rongchuang Biological Co. Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 149. Hangzhou Rongchuang Biological Co. Business Overview
Table 150. Hangzhou Rongchuang Biological Co. Recent Developments
Table 151. Ltd. Drug Safety Testing Basic Information
Table 152. Ltd. Drug Safety Testing Product Overview
Table 153. Ltd. Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 154. Ltd. Business Overview
Table 155. Ltd. Recent Developments
Table 156. WuXi AppTec Drug Safety Testing Basic Information
Table 157. WuXi AppTec Drug Safety Testing Product Overview
Table 158. WuXi AppTec Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 159. WuXi AppTec Business Overview
Table 160. WuXi AppTec Recent Developments
Table 161. Global Drug Safety Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 162. North America Drug Safety Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 163. Europe Drug Safety Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 164. Asia Pacific Drug Safety Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 165. South America Drug Safety Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 166. Middle East and Africa Drug Safety Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 167. Global Drug Safety Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 168. Global Drug Safety Testing Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Drug Safety Testing Market Size Comparison by Region (M USD)
Table 5. Global Drug Safety Testing Revenue (M USD) by Company (2019-2024)
Table 6. Global Drug Safety Testing Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Safety Testing as of 2022)
Table 8. Company Drug Safety Testing Market Size Sites and Area Served
Table 9. Company Drug Safety Testing Product Type
Table 10. Global Drug Safety Testing Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Drug Safety Testing
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Drug Safety Testing Market Challenges
Table 18. Global Drug Safety Testing Market Size by Type (M USD)
Table 19. Global Drug Safety Testing Market Size (M USD) by Type (2019-2024)
Table 20. Global Drug Safety Testing Market Size Share by Type (2019-2024)
Table 21. Global Drug Safety Testing Market Size Growth Rate by Type (2019-2024)
Table 22. Global Drug Safety Testing Market Size by Application
Table 23. Global Drug Safety Testing Market Size by Application (2019-2024) & (M USD)
Table 24. Global Drug Safety Testing Market Share by Application (2019-2024)
Table 25. Global Drug Safety Testing Market Size Growth Rate by Application (2019-2024)
Table 26. Global Drug Safety Testing Market Size by Region (2019-2024) & (M USD)
Table 27. Global Drug Safety Testing Market Size Market Share by Region (2019-2024)
Table 28. North America Drug Safety Testing Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Drug Safety Testing Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Drug Safety Testing Market Size by Region (2019-2024) & (M USD)
Table 31. South America Drug Safety Testing Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Drug Safety Testing Market Size by Region (2019-2024) & (M USD)
Table 33. ArisGlobal LLC Drug Safety Testing Basic Information
Table 34. ArisGlobal LLC Drug Safety Testing Product Overview
Table 35. ArisGlobal LLC Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 36. ArisGlobal LLC Drug Safety Testing SWOT Analysis
Table 37. ArisGlobal LLC Business Overview
Table 38. ArisGlobal LLC Recent Developments
Table 39. Eurofins Drug Safety Testing Basic Information
Table 40. Eurofins Drug Safety Testing Product Overview
Table 41. Eurofins Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 42. Eurofins Drug Safety Testing SWOT Analysis
Table 43. Eurofins Business Overview
Table 44. Eurofins Recent Developments
Table 45. Clario Drug Safety Testing Basic Information
Table 46. Clario Drug Safety Testing Product Overview
Table 47. Clario Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 48. Clario Drug Safety Testing SWOT Analysis
Table 49. Clario Business Overview
Table 50. Clario Recent Developments
Table 51. Charles River Drug Safety Testing Basic Information
Table 52. Charles River Drug Safety Testing Product Overview
Table 53. Charles River Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 54. Charles River Business Overview
Table 55. Charles River Recent Developments
Table 56. Pace Analytical Services Drug Safety Testing Basic Information
Table 57. Pace Analytical Services Drug Safety Testing Product Overview
Table 58. Pace Analytical Services Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 59. Pace Analytical Services Business Overview
Table 60. Pace Analytical Services Recent Developments
Table 61. LabCorp Drug Safety Testing Basic Information
Table 62. LabCorp Drug Safety Testing Product Overview
Table 63. LabCorp Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 64. LabCorp Business Overview
Table 65. LabCorp Recent Developments
Table 66. ICON plc. Drug Safety Testing Basic Information
Table 67. ICON plc. Drug Safety Testing Product Overview
Table 68. ICON plc. Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 69. ICON plc. Business Overview
Table 70. ICON plc. Recent Developments
Table 71. Boston Analytical Drug Safety Testing Basic Information
Table 72. Boston Analytical Drug Safety Testing Product Overview
Table 73. Boston Analytical Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 74. Boston Analytical Business Overview
Table 75. Boston Analytical Recent Developments
Table 76. Catalent Drug Safety Testing Basic Information
Table 77. Catalent Drug Safety Testing Product Overview
Table 78. Catalent Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 79. Catalent Business Overview
Table 80. Catalent Recent Developments
Table 81. Parexel International Corporation Drug Safety Testing Basic Information
Table 82. Parexel International Corporation Drug Safety Testing Product Overview
Table 83. Parexel International Corporation Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 84. Parexel International Corporation Business Overview
Table 85. Parexel International Corporation Recent Developments
Table 86. Altasciences Drug Safety Testing Basic Information
Table 87. Altasciences Drug Safety Testing Product Overview
Table 88. Altasciences Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 89. Altasciences Business Overview
Table 90. Altasciences Recent Developments
Table 91. Hangzhou Huante Biotechnology Co. Drug Safety Testing Basic Information
Table 92. Hangzhou Huante Biotechnology Co. Drug Safety Testing Product Overview
Table 93. Hangzhou Huante Biotechnology Co. Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 94. Hangzhou Huante Biotechnology Co. Business Overview
Table 95. Hangzhou Huante Biotechnology Co. Recent Developments
Table 96. Ltd. Drug Safety Testing Basic Information
Table 97. Ltd. Drug Safety Testing Product Overview
Table 98. Ltd. Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 99. Ltd. Business Overview
Table 100. Ltd. Recent Developments
Table 101. Boende Testing Drug Safety Testing Basic Information
Table 102. Boende Testing Drug Safety Testing Product Overview
Table 103. Boende Testing Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 104. Boende Testing Business Overview
Table 105. Boende Testing Recent Developments
Table 106. Microspectroscopy Technology Co. Drug Safety Testing Basic Information
Table 107. Microspectroscopy Technology Co. Drug Safety Testing Product Overview
Table 108. Microspectroscopy Technology Co. Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 109. Microspectroscopy Technology Co. Business Overview
Table 110. Microspectroscopy Technology Co. Recent Developments
Table 111. Ltd. Drug Safety Testing Basic Information
Table 112. Ltd. Drug Safety Testing Product Overview
Table 113. Ltd. Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 114. Ltd. Business Overview
Table 115. Ltd. Recent Developments
Table 116. Pharmaron Drug Safety Testing Basic Information
Table 117. Pharmaron Drug Safety Testing Product Overview
Table 118. Pharmaron Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 119. Pharmaron Business Overview
Table 120. Pharmaron Recent Developments
Table 121. JOINN Drug Safety Testing Basic Information
Table 122. JOINN Drug Safety Testing Product Overview
Table 123. JOINN Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 124. JOINN Business Overview
Table 125. JOINN Recent Developments
Table 126. Shanghai InnoStar Bio-tech Co. Drug Safety Testing Basic Information
Table 127. Shanghai InnoStar Bio-tech Co. Drug Safety Testing Product Overview
Table 128. Shanghai InnoStar Bio-tech Co. Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 129. Shanghai InnoStar Bio-tech Co. Business Overview
Table 130. Shanghai InnoStar Bio-tech Co. Recent Developments
Table 131. Ltd Drug Safety Testing Basic Information
Table 132. Ltd Drug Safety Testing Product Overview
Table 133. Ltd Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 134. Ltd Business Overview
Table 135. Ltd Recent Developments
Table 136. WESTCHINA-FRONTIE PHARMA TECH Drug Safety Testing Basic Information
Table 137. WESTCHINA-FRONTIE PHARMA TECH Drug Safety Testing Product Overview
Table 138. WESTCHINA-FRONTIE PHARMA TECH Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 139. WESTCHINA-FRONTIE PHARMA TECH Business Overview
Table 140. WESTCHINA-FRONTIE PHARMA TECH Recent Developments
Table 141. Shanghai Medicilon Drug Safety Testing Basic Information
Table 142. Shanghai Medicilon Drug Safety Testing Product Overview
Table 143. Shanghai Medicilon Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 144. Shanghai Medicilon Business Overview
Table 145. Shanghai Medicilon Recent Developments
Table 146. Hangzhou Rongchuang Biological Co. Drug Safety Testing Basic Information
Table 147. Hangzhou Rongchuang Biological Co. Drug Safety Testing Product Overview
Table 148. Hangzhou Rongchuang Biological Co. Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 149. Hangzhou Rongchuang Biological Co. Business Overview
Table 150. Hangzhou Rongchuang Biological Co. Recent Developments
Table 151. Ltd. Drug Safety Testing Basic Information
Table 152. Ltd. Drug Safety Testing Product Overview
Table 153. Ltd. Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 154. Ltd. Business Overview
Table 155. Ltd. Recent Developments
Table 156. WuXi AppTec Drug Safety Testing Basic Information
Table 157. WuXi AppTec Drug Safety Testing Product Overview
Table 158. WuXi AppTec Drug Safety Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 159. WuXi AppTec Business Overview
Table 160. WuXi AppTec Recent Developments
Table 161. Global Drug Safety Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 162. North America Drug Safety Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 163. Europe Drug Safety Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 164. Asia Pacific Drug Safety Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 165. South America Drug Safety Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 166. Middle East and Africa Drug Safety Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 167. Global Drug Safety Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 168. Global Drug Safety Testing Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Industrial Chain of Drug Safety Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug Safety Testing Market Size (M USD), 2019-2030
Figure 5. Global Drug Safety Testing Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Drug Safety Testing Market Size by Country (M USD)
Figure 10. Global Drug Safety Testing Revenue Share by Company in 2023
Figure 11. Drug Safety Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Drug Safety Testing Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Drug Safety Testing Market Share by Type
Figure 15. Market Size Share of Drug Safety Testing by Type (2019-2024)
Figure 16. Market Size Market Share of Drug Safety Testing by Type in 2022
Figure 17. Global Drug Safety Testing Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Drug Safety Testing Market Share by Application
Figure 20. Global Drug Safety Testing Market Share by Application (2019-2024)
Figure 21. Global Drug Safety Testing Market Share by Application in 2022
Figure 22. Global Drug Safety Testing Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Drug Safety Testing Market Size Market Share by Region (2019-2024)
Figure 24. North America Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Drug Safety Testing Market Size Market Share by Country in 2023
Figure 26. U.S. Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Drug Safety Testing Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Drug Safety Testing Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Drug Safety Testing Market Size Market Share by Country in 2023
Figure 31. Germany Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Drug Safety Testing Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Drug Safety Testing Market Size Market Share by Region in 2023
Figure 38. China Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Drug Safety Testing Market Size and Growth Rate (M USD)
Figure 44. South America Drug Safety Testing Market Size Market Share by Country in 2023
Figure 45. Brazil Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Drug Safety Testing Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Drug Safety Testing Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Drug Safety Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global Drug Safety Testing Market Share Forecast by Type (2025-2030)
Figure 57. Global Drug Safety Testing Market Share Forecast by Application (2025-2030)
Figure 1. Industrial Chain of Drug Safety Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug Safety Testing Market Size (M USD), 2019-2030
Figure 5. Global Drug Safety Testing Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Drug Safety Testing Market Size by Country (M USD)
Figure 10. Global Drug Safety Testing Revenue Share by Company in 2023
Figure 11. Drug Safety Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Drug Safety Testing Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Drug Safety Testing Market Share by Type
Figure 15. Market Size Share of Drug Safety Testing by Type (2019-2024)
Figure 16. Market Size Market Share of Drug Safety Testing by Type in 2022
Figure 17. Global Drug Safety Testing Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Drug Safety Testing Market Share by Application
Figure 20. Global Drug Safety Testing Market Share by Application (2019-2024)
Figure 21. Global Drug Safety Testing Market Share by Application in 2022
Figure 22. Global Drug Safety Testing Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Drug Safety Testing Market Size Market Share by Region (2019-2024)
Figure 24. North America Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Drug Safety Testing Market Size Market Share by Country in 2023
Figure 26. U.S. Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Drug Safety Testing Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Drug Safety Testing Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Drug Safety Testing Market Size Market Share by Country in 2023
Figure 31. Germany Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Drug Safety Testing Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Drug Safety Testing Market Size Market Share by Region in 2023
Figure 38. China Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Drug Safety Testing Market Size and Growth Rate (M USD)
Figure 44. South America Drug Safety Testing Market Size Market Share by Country in 2023
Figure 45. Brazil Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Drug Safety Testing Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Drug Safety Testing Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Drug Safety Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Drug Safety Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global Drug Safety Testing Market Share Forecast by Type (2025-2030)
Figure 57. Global Drug Safety Testing Market Share Forecast by Application (2025-2030)
